Dapagliflozin Patient Satisfaction Survey

Trial Identifier: D1690R00026
Sponsor: AstraZeneca
Collaborator:
Optum
NCTID:: NCT02805283
Start Date: June 2016
Primary Completion Date: October 2018
Study Completion Date: October 2018
Condition: Diabetes: Type 2

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations